Moderna stock downgrade: Openheimer analyst discusses why he downgraded the stock to neutral August 17, 2021 9:21 am by IWB Hartaj Singh, Oppenheimer Analyst, joins Yahoo Finance to discuss downgrading Moderna earlier this month, future outlook on the stock, and questions around booster shots.